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The pathogenic significance of the increased association of systemic lupus erythem- 
atosus (SLE) with certain structures of the major histocompatibility complex (MHC) 
(1-4)  is unknown. An experimental model of SLE, in which MHC structures play a 
defined  pathogenic  role,  is  the  induction  of  an  SLE-like  graft-vs.-host  reaction 
(GVHR)  in nonirradiated F1 mice (5). In this model, the injection of donor T  cells 
and  an  H-2  incompatibility in  the  F1  recipients, regardless  of the haplotype, was 
required  for the  formation of all  autoantibodies studied  (6-8).  The  autoantibody 
formation during the GVHR is probably the outcome of two consecutive steps. First, 
alloreactive donor T  helper (Tn) cells react against H-2-incompatible B cells and/or 
macrophages of the F1 recipient. Thereafter, this reaction, in combination with self- 
antigen, leads to a positive allogeneic effect that preferentially triggers those F1 B cells 
that produce autoantibodies characteristic of SLE (5). 
Loci within the I  region of H-2, I-A, and I-E code for determinants that control 
antigen presentation and the interactions ofT cells with B cells and maerophages (9). 
Incompatibilities at I-A and/or I-E cause a strong stimulation in the mixed lympho- 
cyte reaction (MLR)  (10,  11) and the GVH splenomegaly assay (12). In the present 
paper, we report  that induction of a  GVHR across I-E triggered the formation of 
autoantibodies characteristic of SLE. 
Materials and Methods 
Mice. Strains  B10.A(2R)  and  B10.A(4R)  were  purchased  from  Olac  1976  Ltd.  (Bicester, 
Oxon,  United  Kingdom),  and  [B10.A(2R)  ×  B10.A(4R)]Fx  mice  were  bred  in  our  animal 
facilities. Female mice, 8-10 wk old, were used. The H-2 genotypes of the strains of mice used 
are shown in Table I. 
Induction of  GVHR. Single-cell suspensions of donor spleen and lymph node cells were prepared 
as  described  previously  (6). Cell  suspensions contained  approximately one part  lymph-node 
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TABLE  I 
H-2 Genotypes of Strains of Mice Used 
Alleles  at H-2 (sub)regions 
K  S  D 
H-2  Strain  I  haplotypes 
A  B  J  E  C 
B10.A(2R)  h2  k  k 
BI0.A(4R)  h4  k  k 
[BI0.A(2R) × BI0,A(4R)]F,  h2 × h4  k  k 
k  k  k  d  d 
b  b  (b)*  b  b 
k/b  k/b  k/(b)*  d/b  d/b 
* The I-E  b allele  does not phenotypically  express  an E. chain (13). See Discussion  for details. 
cells and two parts spleen cells. Nonirradiated F1 recipient mice were injected intravenously 
with 50 ×  106 viable donor cells on both day 0 and day 7. 
Detection of Autoantibodies. Autoantibodies to  thymocytes were detected by a  complement- 
dependent cytotoxicity test, and the cytotoxic index (CI) was determined as described (6). 51Cr- 
labeled thymocytes from normal [B10.A(2R)  ×  B10.A(4R)]F1 mice were used as target cells. 
IgG autoantibodies to erythrocytes were detected by the direct Coombs' test (5). IgG antibodies 
against nuclear antigens were determined by use of an indirect immunofluorescence technique 
using a fluorescein-labeled rabbit anti-mouse IgG serum; cryostat sections of mouse liver were 
used  as antigenic substrate as described (7).  IgG antibodies reacting exclusively to double- 
stranded DNA (dsDNA) were determined as described (8). 
Results 
Untreated  B10.A(2R)  (n =  10),  B10.A(4R)  (n =  40),  and  [B10.A(2R)  × 
B 10.A(4R)]F1 (n =  10)  mice served as negative controls. All these mice were bled and 
tested  at  8  and  20  wk  of age.  None  of them  had  spontaneous  autoantibodies  to 
thymocytes,  erythrocytes,  nuclear  antigens,  or  dsDNA.  The  administration  of 
B10.A(4R)  lymphocytes to F~ mice induced the formation of autoantibodies against 
thymocytes, erythrocytes, nuclear  antigens,  and  dsDNA  in  all of the  recipients.  In 
marked  contrast,  none  of the  F1  mice  injected  with  lymphocytes  from  B10.A(2R) 
produced  autoantibodies  to  erythrocytes  or  dsDNA;  moreover,  autoantibodies  to 
nuclear antigens  appeared  in just  two  F1  recipients, and  only one  Fa  mouse  of the 
total group had anti-thymocyte antibodies in the serum giving a CI value >30 (Table 
II). 
Discussion 
The mainly negative results obtained with the donor B 10.A(2R)  indicate that the 
H-2  incompatibilities in the  F1  recipients at  the subregions I-B, I-J, I-C, and  the  S 
region  were  too  weak  to  trigger  SLE-like  autoantibody  formation.  This  finding 
conforms  with  the  inability of these  H-2  (sub)regions  to  evoke  a  significant  GVH 
splenomegaly  (12)  or MLR  reactivity (10,  14).  In contrast, when  B10.A(4R)  donor 
cells were used for the induction of GVHR,  autoantibody formation ensued.  In this 
case, the only incompatibility, other than those at I-B, I-J, I-C, and S, against which 
the B10.A(4R)  cells could react, was that determined by the I-E  k subregion of the Fl 
recipients (Table I). It is known that the molecular product of the I-E subregion, the 
E~ chain,  has  to combine with  the E/~ chain, coded for by the  I-A subregion,  to be 
expressed as a  two-chain molecule on  the cell surface  (13). The crucial point here is 
that  strains of mice possessing a  b,  f,  q,  or s  allele at  I-E do not  express the E,/Ea 
molecule on  the cell surface.  One  such  nonexpressor strain  is BI0.A(4R)  (I-Eb).  By T
A
n
L
E
 
I
I
 
F
o
r
m
a
t
i
o
n
 
o
f
 
S
L
E
-
L
t
k
e
 
A
u
t
o
a
n
t
i
b
o
d
i
e
s
 
i
n
 
[
 
B
 
I
 
O
.
A
 
(
2
R
 
)
 
X
 
B
 
I
 
O
.
A
 
(
4
R
)
 
]
 
F
t
 
M
i
c
e
 
I
n
j
e
c
t
e
d
 
w
i
t
h
 
1
0
 
8
 
P
a
r
e
n
t
a
l
 
S
t
r
a
i
n
 
L
y
m
p
h
o
c
y
t
e
s
 
<
 
>
 
X
 
7
0
 
>
 
>
 
7
0
 
F
I
 
m
i
c
e
 
w
i
t
h
 
a
u
t
o
a
n
t
i
b
o
d
i
e
s
 
a
g
a
i
n
s
t
 
W
e
e
k
s
 
a
f
t
e
r
 
f
i
r
s
t
 
N
u
m
b
e
r
 
o
f
 
F
~
 
i
n
j
e
c
t
i
o
n
 
o
f
 
d
o
n
o
r
 
m
i
c
e
 
t
e
s
t
e
d
 
c
e
l
l
s
 
E
r
y
t
h
r
o
c
y
t
e
s
 
T
h
y
m
o
c
y
t
e
s
 
N
u
c
l
e
a
r
 
a
n
t
i
g
e
n
s
 
P
e
r
c
e
n
t
 
a
t
 
P
e
r
c
e
n
t
 
a
t
 
M
e
a
n
 
C
I
 
P
e
r
c
e
n
t
 
a
t
 
M
e
a
n
 
l
o
g
 
P
e
r
c
e
n
t
 
a
t
 
C
u
m
u
l
a
t
i
v
e
 
C
u
m
u
l
a
t
i
v
e
 
v
a
l
u
e
s
 
:
t
:
 
S
E
 
C
u
m
u
l
a
t
i
v
e
 
t
i
t
e
r
 
o
f
 
t
i
m
e
 
t
i
m
e
 
t
i
m
e
 
t
i
m
e
 
i
n
d
i
c
a
t
e
d
 
p
e
r
c
e
n
t
 
i
n
d
i
c
a
t
e
d
*
 
p
e
r
c
e
n
t
*
 
o
f
 
t
o
t
a
l
 
i
n
d
i
c
a
t
e
d
 
p
e
r
c
e
n
t
 
p
o
s
i
t
i
v
e
 
i
n
d
i
c
a
t
e
d
 
g
r
o
u
p
 
m
i
c
e
:
~
 
d
s
D
N
A
 
C
u
m
u
l
a
t
i
v
e
 
p
e
r
c
e
n
 
t
 
M
e
a
n
 
l
o
g
 
t
i
t
e
r
 
o
f
 
p
o
s
i
t
,
 
m
i
c
e
.
~
 
>
 
Z
 
7
0
 
<
 
Z
 
D
o
n
o
r
 
B
 
1
0
.
A
(
2
R
)
 
1
 
1
6
 
0
 
0
 
0
 
0
 
6
 
±
 
4
 
0
 
0
 
<
1
 
0
 
0
 
<
1
 
5
 
1
6
 
0
 
0
 
6
 
6
 
8
 
-
-
-
 
5
 
0
 
0
 
<
1
 
0
 
0
 
<
1
 
9
 
1
5
 
0
 
0
 
7
 
7
 
3
 
-
 
3
 
7
 
7
 
1
.
0
 
0
 
0
 
<
1
 
1
3
 
1
4
 
0
 
0
 
0
 
7
 
5
 
-
+
 
2
 
7
 
7
 
2
.
5
 
0
 
0
 
<
1
 
1
7
 
1
2
 
0
 
0
 
0
 
7
 
3
 
-
+
 
3
 
1
7
 
1
7
 
2
.
4
 
0
 
0
 
<
1
 
>
 
t
"
 
t
~
 
D
o
n
o
r
 
B
 
1
0
.
A
(
4
R
)
 
7
0
 
1
 
1
6
 
0
 
0
 
[
)
 
0
 
5
 
+
 
3
 
0
 
0
 
<
1
 
0
 
0
 
<
1
 
5
 
1
5
 
4
0
 
4
0
 
8
7
 
9
3
 
4
4
 
:
i
:
 
2
 
1
0
0
 
1
0
0
 
3
.
3
 
1
0
0
 
1
0
0
 
1
.
8
 
9
 
1
2
 
9
2
 
9
4
 
7
5
 
9
3
 
3
8
 
+
 
2
 
1
0
0
 
1
0
0
 
3
.
7
 
8
3
 
1
0
0
 
2
.
7
 
t
2
 
1
3
 
9
 
4
4
 
1
0
0
 
8
9
 
9
3
 
4
9
 
±
 
3
 
1
0
0
 
1
0
0
 
3
.
7
 
1
0
0
 
1
0
0
 
2
.
2
 
1
7
 
9
 
2
2
 
1
0
0
 
8
9
 
l
(
h
'
)
 
4
2
 
-
-
_
 
3
 
1
0
0
 
1
0
0
 
3
.
8
 
1
0
0
 
1
0
0
 
2
.
1
 
*
 
O
n
l
y
 
t
h
o
s
e
 
F
t
 
m
i
c
e
 
w
h
o
s
e
 
s
e
r
a
 
g
a
v
e
 
a
 
C
I
 
>
3
0
 
w
e
r
e
 
c
o
n
s
i
d
e
r
e
d
 
t
o
 
b
e
 
p
o
s
i
t
i
v
e
,
 
b
e
c
a
u
s
e
 
n
o
r
m
a
l
 
m
i
c
e
 
m
a
y
 
h
a
v
e
 
s
e
r
u
m
 
a
n
t
i
b
o
d
i
e
s
 
t
o
 
t
h
y
m
o
c
y
t
e
s
,
 
w
h
i
c
h
 
g
i
v
e
 
C
I
 
w
i
t
h
 
t
h
e
 
n
o
r
m
a
l
 
m
o
u
s
e
 
s
e
r
u
m
 
u
s
e
d
 
a
s
 
r
e
f
e
r
e
n
c
e
.
 
:
~
 
A
l
l
 
S
E
 
v
a
l
u
e
s
 
o
f
 
l
o
g
 
t
i
t
e
r
s
 
i
n
 
t
h
i
s
 
c
o
l
u
m
n
 
w
e
r
e
 
~
<
0
.
2
.
 
v
a
l
u
e
s
 
u
p
 
t
o
 
3
0
 
w
h
e
n
 
c
o
m
p
a
r
e
d
 
,
q
 
r
O
 
7
0
 
©
 
7
0
 
,
-
q
 
.
,
-
.
1
 1558  VAN  RAPPARD-VAN  DER  VEEN  ET  AL.  BRIEF  DEFINITIVE REPORT 
contrast, strain B 10.A(2R) (I-E  k) does express the EJEa molecule (t3). Hence, T cells 
of B 10.A(2R) were not exposed to an I-E incompatibility on B cells and macrophages 
of [B 10.A(2R) ×  B 10.A(4R)]F1 recipient mice, whereas the T cells of B 10.A(4R) could 
react against  the E,k/EB  k molecule expressed by such Fa mice (9,  13). This one-way 
reaction between lymphoid cells of these strains explains (9) the previous observations 
that mixed-lymphocyte reactivity (10,  14) and GVH splenomegaly (12) occur only in 
the direction B 10.A(4R) anti-B10.A(2R) and not in the opposite direction. The same 
unidirectionality was found in the present study on the induction by GVHR of SLE- 
like autoantibodies (Table II). 
Thus, our results indicate that an incompatibility at I-E alone provided the stimulus 
that  led  to  the  massive  formation  of autoantibodies  characteristic  of SLE.  The 
observed formation of high titers of IgG antibodies to dsDNA (Table II) is especially 
remarkable because dsDNA has proved to be a very poor immunogen in conventional 
immunization  procedures  (15).  In  all  likelihood,  the  initial  reaction  leading  to 
autoantibody formation was made by the alloreactive TH cells of the donor B 10.A(4R) 
against the E,k/Ep  k molecule present on F1 macrophages and/or B cells. 
An intriguing aspect of these findings is that I-E appears to be the murine analogue 
of HLA-D/DR  (16,  17). Therefore, our findings are of interest with respect  to the 
increased  frequency of certain  HLA-DR alleles in  patients with  SLE  (1-4).  It  has 
been proposed that the formation of autoantibodies in SLE might be due to a GVH- 
like abnormal cooperation between autologous T  and B cells (5). The postulated role 
of HLA-D/DR  in  this process would  be to combine with etiologic agents,  such  as 
viruses or drugs, and then provide an immunogenic stimulus to autologous TH cells. 
Thereafter, the activated TH cells might, in a GVH-like fashion, trigger the normally 
existing autoreactive B cells involved in SLE (5).  Recent studies performed in mice 
with the SLE-inducing drug diphenylhydantoin are consistent with this concept (18). 
Conceivably, a given etiologic agent becomes strongly immunogenic for TH cells only 
in combination with one or a  few alleles of HLA-D/DR, or closely linked loci. This 
concept might explain why some groups of patients  with  idiopathic  SLE show an 
increased frequency with HLA-DR3 (1, 2), whereas in others, possibly exposed to a 
different etiologic agent, there seems to be an association with HLA-DR2 (1, 3). When 
patients with  hydralizine-induced SLE were studied,  an  increased association with 
HLA-DR4 was found (4). Thus, regardless of the variable etiology of SLE, these are 
products of the same locus, HLA-DR, that appear to be involved in the pathogenesis 
of the  disease.  The involvement in  a  well-defined model of SLE of the  analogous 
murine locus, I-E, may help to understand these intriguing pathogenic relationships. 
Summary 
By induction of a suitable graft-vs-host reaction (GVHR) in H-2-different F1 mice, 
one  can  induce  the  production  of autoantibodies  characteristic  of systemic  lupus 
erythematosus (SLE). The purpose of the present study was to define the intra-H-2 
differences in the F~ recipients that are capable of triggering this process. A GVHR 
was induced in [B10.A(2R)  ×  B10.A(4R)]F1 mice by injecting 10  8 lymphocytes from 
either parental strain. Whereas the donor B 10.A(4R) induced a massive formation of 
autoantibodies  to  thymocytes, erythrocytes, nuclear  antigens,  and  double-stranded 
DNA, the donor B 10.A(2R) failed to do so. The intra-H-2 genetics of these two parent 
---~F1 combinations  are  such  that  the  observed  autoantibody  formation  after  the VAN RAPPARD-VAN DER  VEEN  ET  AL.  BRIEF DEFINITIVE REPORT  1559 
injection of B 10.A(4R) T  cells must have been triggered exclusively by the incompat- 
ible I-E  k subregion of the [B 10.A(2R) ×  B 10.A(4R)]F1 recipients. Because I-E appears 
to be the murine analogue of HLA-D/DR,  this finding is of interest with respect to 
the increased frequency of certain HLA-DR  alleles in SLE patients, as discussed. 
Received  for publication 25January  1982. 
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